PROGRAM

View Program Timetable

Global and Regional Challenges for 2002 and Beyond

Tuberculosis - Current issues

Malaria - Resistance issues

Paramyxovirus - the next generation

Diseases of Developing Nations

Management of Otitis Media

HepC Management

Viral Co-infections

Pharmacodynamics - the clinical evidence

Cryptococcus

Resistance mechanisms

Resistance surveillance - What value?

Community MRSA

Evidence based treatment

HIV - opportunistic infections (immunotherapy, co-infections)

VRE & GISA in the Western Pacific

Vaccines

Role of the regulator in antimicrobial prescribing

VCJD

Antibiotic use in animals (a Western Pacific perspective)

Antibiotic guidelines - principles versus practice

Understanding the Sepsis Syndrome (options for therapeutic intervention)

SPEAKERS - Plenary Sessions

PATRICE COURVALIN
'Why are bacteria becoming resistant?'

Professor Patrice Courvalin is head of the Department of Fundamental and Medical Microbiology and head of the Antibacterial Agents Unit at the Institut Pasteur, Paris, France. He works extensively on the molecular mechanisms of resistance and is well known for elucidating the molecular basis of vancomycin resistance in enterococci. Other areas of research are on the genetics of quinolone resistance in Streptococcus pneumoniae and rifampicin resistance in staphylococci. He is also involved in European resistance surveillance programs and in the quality assessment of susceptibility testing. He is an expert adviser in the area of antibiotics to the European Commission, Coordinator for France of the European Antimicrobial Resistance Surveillance System, and a Member of the Scientific Advisory Board of the International Surveillance Program for Emerging Antimicrobial Resistance

TONY MCMICHAEL
'Microbial consequences of environmental and social change'

Tony McMichael is the newly-appointed Director of the National Centre for Epidemiology and Population Health at the Australian National University, Canberra. Previously he was Professor of Epidemiology at the London School of Hygiene and Tropical Medicine, London, UK. His research interests have encompassed occupational diseases, diet and cancer, and environmental health hazards. More recently, he has concentrated his research upon assessing the health risks from global environmental change - and since 1994 he has chaired the health impact assessment for the UN's Intergovernmental Panel on Climate Change. He is a member of WHO's Expert Committee on Globalisation and Health, and of the International Science Council on Population and Environment. In 1993, he published "Planetary Overload: Global Environmental Change and the Health of the Human Species". In 2001, new book "Human Frontiers, Environments and Disease: Past Patterns, Uncertain Futures" was released.

BARRY MARSHALL
'Advances in the Understanding of the Helicobacters'

Barry Marshall is the Burnet Fellow at the University of Western Australia. He and Robyn Warren were responsible for the first isolation of Helicobacter pylori and for establishing the association between infection with the organism and gastritis and peptic ulceration. He has a continuing research and clinical interest in Helicobacter pylori. His major interests are in the diagnosis of infection, including the development of diagnostic tests, the association of H. pylori with other clinical entities and treatment.

LAM SAI KIT
'Dengue: Past Experiences and Future Prospects'

Professor Lam Sai Kit is head of the Department of Medical Microbiology in the Faculty of Medicine at the University of Malaya. He has an international reputation for virological research, especially into viruses of importance in the tropics and SE Asia. His work includes clinical and laboratory on Dengue, enterovirus 71 and more recently Nipah virus. His Department is a WHO Collaborating Centre in Influenza.

WESTERN PACIFIC REGIONAL SPEAKERS

AUSTRALIA
David Anderson
Jan Bell
Richard Benn
Frank Christiansen
Keryn Christiansen
Peter Collignon
Geoffrey Coombs
Bart Currie
Tim Davis
Geoffrey Dobb
Dominic Dwyer
David Ellis
Frank Fenner
John Ferguson
James Flexman
Ian Frazer
Martyn French
Suzanne Garland
Lyn Gilbert
Clayton Golledge
Michael Good
David Gordon
Iain Gosbell
Tom Gottlieb
Lindsay Grayson
Warren Grubb
John Hall
Robert Hall
Tim Inglis
Louis Irving
David Isaacs
Cheryl Jones
Stephen Kent
Amanda Leach
Diane Lightfoot
Gary Lum
Peter MacIntyre
Simon Mallal
Barry Marshall
Debbie Marriott
Patricia Martinez
Colin Masters
Tony McMichael
Deborah Middleton
Wendy Munckhof
Graeme Nimmo
Terry Nolan
John Pearman
William Rawlinson
Craig Rayner
Karl Reickmann
Peter Richmond
Julian Rood
David Smith
Tania Sorrell
Joseph Torresi
John Turnidge
Justin Waring
Grant Waterer
Jonathan Webber
Lynn Weekes
Roger Wilson

CHINA (HONG KONG)
Donald Lyon
Malik Peiris
Wing-Hong Seto
Kenneth Tsang
Wing Wai Yew

CHINA (PEOPLE'S REPUBLIC)
Hui Wang

JAPAN
Keiichi Hiramatsu
Matsuhisa Inoue
Masatoshi Tanaka
Kyuichi Tanikawa

KOREA
Yong-Hyun Cho
Jae-Hoon Song

MALAYSIA
Adeeba Kamarulzaman
Lam Sai Kit
Christopher Lee
Victor Lim

NEW ZEALAND
Stephen Chambers
Diana Martin
David Murdoch

PHILIPPINES
Thelma Tupasi-Ramos

THAILAND
Tararaj Dharakul
Mattana Hanvanich
Somsak Lolekha
Sirirurg Songsivilai
Somying Tumwasorn

SYMPOSIA

Clinical Relevance of Resistance in Streptococcus pneumoniae

BSE and vCJD

Information Technology and Infectious Diseases

Antifungal Therapy I

Group A Streptococcus

Role of the Clinical Laboratory in Infection Control

Resistance - A Major Problem for the Western Pacific

Infections in Pregnancy - Preventing Vertical Transmission

Nosocomial Infections

Antimicrobial Pharmacodynamics - the Science of Dosing

Antifungal Therapy 2

Conjugate Pneumococcal Vaccines

Antibiotic Use in Animals - Implications for Human Health

Tuberculosis

Issues Complicating Antiretroviral Therapy for HIV

Malaria

Mechanisms and Clinical Significance of Resistance in Staphylococcus aureus

Meningococcal Infection

Salmonella - Forgotten but not Gone

MRSA

Community Acquired Pneumonia and Other Lower Respiratory Tract Infections
(partially sponsored by the Hong Kong Thoracic Society)

Opportunistic Infections and Co-Infections in HIV Patients

The Ins and Outs of Antibiotic Resistance

Sexually Transmitted Diseases in the Western Pacific
(sponsored by the Japanese Society of Chemotherapy)

Immunotherapy for Chronic Viral Infections

Resistance Management Programs - Every Country Should Have One

Ethics and Immunisation

Implant Associated Infection

New Antiviral Agents

Clostridial Infections

Glycopeptide- Resistant Enterococci (GRE) - Local Aspects of a Global Problem

Influenza Virus Infections

Is This True?

Melioidiosis

Hepatitis B Virus